Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival June 05, 2026Vol.52 No.22By Jacquelyn Cobb
Trials & Tribulations The story of daraxonrasib is the ultimate hero’s journeyA narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe June 05, 2026Vol.52 No.22By W. Kimryn Rathmell
Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final June 05, 2026Vol.52 No.22By Paul Goldberg and Claire Marie Porter
At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer June 05, 2026Vol.52 No.22By Sara Willa Ernst, Claire Marie Porter and Paul Goldberg
Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.” June 05, 2026Vol.52 No.22By Claire Marie Porter
Cancer Policy Cancer patients could be exempted from Medicaid work requirements if they prove they are “medically frail” June 05, 2026Vol.52 No.22By Sara Willa Ernst
In Brief Mina Sedrak and Vijaya Raj Bhatt to co-lead Alliance’s committee on cancer care for older adults June 05, 2026Vol.52 No.22
In Brief Labcorp and Alliance partner to support multi-institution trial to expand genetic testing in CRC June 05, 2026Vol.52 No.22
In Brief Advocate Health partners with AI startup to connect more cancer patients to clinical trials June 05, 2026Vol.52 No.22
